Skip to main content
SpringerLink
Log in

Adherence to Treatment Regimes in Adolescent and Young Adult Cancer Patients

  • Chapter
  • First Online:
Cancer in Adolescents and Young Adults

Part of the book series: Pediatric Oncology ((PEDIATRICO))

Abstract

Adherence, defined as the extent to which a patient’s behavior coincides with medical or health advice, can have significant implications for AYA with cancer. Some of the facilitators of and barriers to adherence for the AYA population are similar to those confronting pediatric and adult populations, while others are distinct and unique to this age group. Best evaluated through a biopsychosocial model, unique barriers for AYAs include the impact of illness on physical well-being as physical development proceeds, the importance of “normality” in this age range, the impact of peer interaction, progressive evolution of the relationship with parents, and the distractibility that may mark adolescence. This evolution continues through young adulthood, a period of increasing and shifting behavioral, financial, social, and familial responsibilities.

A developmentally oriented framework for considering adherence among AYA with cancer is critical and encompasses specific approaches to enhancing patient engagement in the treatment process and the healthcare system, including the use of electronic gaming and monitoring; attention to the state of evolution of patient’ cognitive and emotional functioning and psychological status; evaluation of patients’ knowledge, belief framework around locus of control in health and illness; the AYA’s perception of severity of illness and the related perception of vulnerability or invulnerability; and the dynamics of the relationship between healthcare providers and AYA patients, with particular emphasis on open and collaborative interaction.

When coupled with knowledge of potential tools to assess adherence, this framework can position providers to better address and support adherence among this population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Haynes RB, McDonald H, Garg AX, Montague P (2002) Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev (2):CD000011

    Google Scholar 

  2. Haynes RB, Sackett DL, Taylor DW (1979) Compliance in health care, vol xvi. Johns Hopkins University Press, Baltimore, p 516

    Google Scholar 

  3. Fletcher RH (1989) Patient compliance with therapeutic advice: a modern view. Mt Sinai J Med 56:453–458

    CAS  PubMed  Google Scholar 

  4. World Health Organization (2003) Adherence to long-term therapies: evidence for action. World Health Organization, Geneva

    Google Scholar 

  5. Leader A, Raanani P (2014) Adherence-related issues in adolescents and young adults with hematological disorders. Acta Haematol 132:348–362

    Article  PubMed  Google Scholar 

  6. Edelstein L (1987) Ancient medicine. Johns Hopkins University Press, Baltimore

    Google Scholar 

  7. Prioreschi P (1995) The Hippocratic Oath: a code for physicians, not a Pythagorean manifesto. Med Hypotheses 44:447–462

    Article  CAS  PubMed  Google Scholar 

  8. Daschner F, Marget W (1975) Treatment of recurrent urinary tract infection in children. II. Compliance of parents and children with antibiotic therapy regimen. Acta Paediatr Scand 64:105–108

    Article  CAS  PubMed  Google Scholar 

  9. McCue DA, Lohr LK, Pick AM (2014) Improving adherence to oral cancer therapy in clinic practice. Pharmacotherapy 34:481–494

    Article  PubMed  Google Scholar 

  10. Butow P, Palmer S, Pai A, Goodenough B, Luckett T, King M (2010) Review of adherence-related issues in adolescents and young adults with cancer. J Clin Oncol 28:4800–4809

    Article  PubMed  Google Scholar 

  11. Mitchell AE, Scarcella DL, Rigutto GL, Thursfield VJ, Giles GG, Sexton M, Ashley DM (2004) Cancer in adolescents and young adults: treatment and outcome in Victoria. Med J Aust 180:59–62

    PubMed  Google Scholar 

  12. Christie D, Viner R (2005) Adolescent development. BMJ 330:301–304

    Article  PubMed  PubMed Central  Google Scholar 

  13. McIntosh N, Helms P, Smyth R (2003) Forfar and Arneil’s textbook of paediatrics, 6th edn. Churchill Livingstone, Edinburgh, pp 1757–1768

    Google Scholar 

  14. Denison JA, Banda H, Dennis AC, Packer C, Nyambe N, Stalter RM, Mwansa JK, Katayamoyo P, McCarraher DR (2015) The sky is the limit: adhering to antiretroviral therapy and HIV self-management from the perspectives of adolescents living with HIV and their adult caregivers. J Int AIDS Soc 18:19358

    Article  PubMed  PubMed Central  Google Scholar 

  15. Bishop J, Lemberg DA, Day A (2014) Managing inflammatory bowel disease in adolescent patients. Adolesc Health Med Ther 5:1–13

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Borus JS, Laffel L (2010) Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention. Curr Opin Pediatr 22:405–411

    Article  PubMed  PubMed Central  Google Scholar 

  17. Goldbeck L, Fidika A, Herle M, Quittner AL (2014) Psychological interventions for individuals with cystic fibrosis and their families. Cochrane Database of Syst Rev (6):CD003148

    Google Scholar 

  18. Hanghoj S, Boisen KA (2014) Self-reported barriers to medication adherence among chronically ill adolescents: a systematic review. J Adolesc Health 54:121–138

    Article  PubMed  Google Scholar 

  19. Arnett JJ (2000) Emerging adulthood: a theory of development from the late teens through the twenties. Am Psychol 55:469–480

    Article  CAS  PubMed  Google Scholar 

  20. Wood WA, Lee SJ (2011) Malignant hematologic diseases in adolescents and young adults. Blood 117:5803–5815

    Article  CAS  PubMed  Google Scholar 

  21. Prior M, McManus M, White P, Davidson L (2014) Measuring the “triple aim” in transition care: a systematic review. Pediatrics 134:e1648–e1661

    Article  PubMed  Google Scholar 

  22. Buchanan ND, Block R, Smith AW, Tai E (2014) Psychosocial barriers and facilitators to clinical trial enrollment and adherence for adolescents with cancer. Pediatrics 133(Suppl 3):S123–S130

    Article  PubMed  PubMed Central  Google Scholar 

  23. Stock W, Luger SM, Advani AS et al (2014) Favorable outcomes for older adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL): early results of U.S. intergroup trial C10403. ASH Annual Meeting and Exposition, available at: ash.cafex.cm/ash/2014/webprogram/papertopics (accessed march 10, 2015) Blood 2014;124(21)abstract 796

    Google Scholar 

  24. Lukenbill J, Advani AS (2013) The treatment of adolescents and young adults with acute lymphoblastic leukemia. Curr Hematol Malig Rep 8:91–97

    Article  PubMed  Google Scholar 

  25. Verbrugghe M, Verhaeghe S, Lauwaert K, Beeckman D, Van Hecke A (2013) Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treat Rev 39:610–621

    Article  CAS  PubMed  Google Scholar 

  26. Kondryn HJ, Edmondson CL, Hill J, Eden TO (2011) Treatment non-adherence in teenage and young adult patients with cancer. Lancet Oncol 12:100–108

    Article  PubMed  Google Scholar 

  27. Cohen DG (1986) Treatment refusal in adolescents. Semin Oncol Nurs 2:112–116

    Article  CAS  PubMed  Google Scholar 

  28. Taliaferro LA, Borowsky IW (2012) Beyond prevention: promoting healthy youth development in primary care. Am J Public Health 102(Suppl 3):S317–S321

    Article  PubMed  PubMed Central  Google Scholar 

  29. Chung RJ, Burke PJ, Goodman E (2010) Firm foundations: strength-based approaches to adolescent chronic disease. Curr Opin Pediatr 22:389–397

    Article  PubMed  Google Scholar 

  30. Duncan PM, Garcia AC, Frankowski BL, Carey PA, Kallock EA, Dixon RD, Shaw JS (2007) Inspiring healthy adolescent choices: a rationale for and guide to strength promotion in primary care. J Adolesc Health 41:525–535

    Article  PubMed  Google Scholar 

  31. Whyte F, Smith L (1997) A literature review of adolescence and cancer. Eur J Cancer Care 6:137–146

    Article  CAS  Google Scholar 

  32. Bleyer A (2007) Young adult oncology: the patients and their survival challenges. CA Cancer J Clin 57:242–255

    Article  PubMed  Google Scholar 

  33. Bhatia S, Landier W, Shangguan M et al (2012) Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children’s oncology group. J Clin Oncol 30:2094–2101

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Kato PM, Cole SW, Bradlyn AS, Pollock BH (2008) A video game improves behavioral outcomes in adolescents and young adults with cancer: a randomized trial. Pediatrics 122:e305–e317

    Article  PubMed  Google Scholar 

  35. Tamaroff MH, Festa RS, Adesman AR, Walco GA (1992) Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates. J Pediatr 120:812–817

    Article  CAS  PubMed  Google Scholar 

  36. Tebbi CK, Cummings KM, Zevon MA, Smith L, Richards M, Mallon J (1986) Compliance of pediatric and adolescent cancer patients. Cancer 58:1179–1184

    Article  CAS  PubMed  Google Scholar 

  37. Malbasa T, Kodish E, Santacroce SJ (2007) Adolescent adherence to oral therapy for leukemia: a focus group study. J Pediatr Oncol Nurs 24:139–151

    Article  PubMed  Google Scholar 

  38. Blotcky AD, Cohen DG, Conatser C, Klopovich P (1985) Psychosocial characteristics of adolescents who refuse cancer treatment. J Consult Clin Psychol 53:729–731

    Article  CAS  PubMed  Google Scholar 

  39. Jamison RN, Lewis S, Burish TG (1986) Cooperation with treatment in adolescent cancer patients. J Adolesc Health Care 7:162–167

    Article  CAS  PubMed  Google Scholar 

  40. Rabiau M, Knäuper B, Miquelon P (2006) The eternal quest for optimal balance between maximizing pleasure and minimizing harm: the compensatory health beliefs model. Br J Health Psychol 11:139–153

    Article  Google Scholar 

  41. Tebbi CK, Richards ME, Cummings KM, Zevon MA, Mallon JC (1988) The role of parent-adolescent concordance in compliance with cancer chemotherapy. Adolescence 23:599–611

    CAS  PubMed  Google Scholar 

  42. Morisky DE, Green LW, Levine DM (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24:67–74

    Article  CAS  PubMed  Google Scholar 

  43. Friedman IM, Litt IF (1986) Promoting adolescents’ compliance with therapeutic regimens. Pediatr Clin North Am 33:955

    Article  CAS  PubMed  Google Scholar 

  44. Ryan R, Santesso N, Lowe D, Hill S, Grimshaw J, Prictor M, Kaufman C, Cowie G, Taylor M (2014) Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews. Cochrane Database Syst Rev (4):CD007768

    Google Scholar 

  45. Pritchard MT, Butow PN, Stevens MM, Duley JA (2006) Understanding medication adherence in pediatric acute lymphoblastic leukemia: a review. J Pediatr Hematol Oncol 28:816–823

    Article  CAS  PubMed  Google Scholar 

  46. Rodewald LE, Pichichero ME (1993) Compliance with antibiotic therapy: a comparison of deuterium oxide tracer, urine bioassay, bottle weights, and parental reports. J Pediatr 123:143–147

    Article  CAS  PubMed  Google Scholar 

  47. Relling MV, Gardner EE, Sandborn WJ, Schmiegelow K, Pui CH, Yee SW et al (2013) Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update. Clin Pharmacol Ther 93:324–325

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Feinstein AR (1990) On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 150:1377–1378

    Article  CAS  PubMed  Google Scholar 

  49. Rudd P, Byyny RL, Zachary V et al (1989) The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther 46:169–176

    Article  CAS  PubMed  Google Scholar 

  50. Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23:1296–1310

    Article  CAS  PubMed  Google Scholar 

  51. Cramer JA (1995) Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 49:321–327

    Article  CAS  PubMed  Google Scholar 

  52. Diaz E, Levine HB, Sullivan MC et al (2001) Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J Psychiatry Neurosci 26:325–329

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Roth HP, Caron HS (1978) Accuracy of doctors’ estimates and patients’ statements on adherence to a drug regimen. Clin Pharmacol Ther 23:361–370

    Article  CAS  PubMed  Google Scholar 

  54. Liptak GS (1996) Enhancing patient compliance in pediatrics. Pediatr Rev 17:128–134

    Article  CAS  PubMed  Google Scholar 

  55. Sackett DL (1991) Helping patients follow the treatments you prescribe. In: Sackett DL, Haynes RB, Guyatt GH (eds) Helping patients follow the treatments you prescribe. Clinical epidemiology: a basic science for clinical medicine. Little Brown, Boston, p 249

    Google Scholar 

  56. Matsui D, Hermann C, Klein J, Berkovitch M, Olivieri N, Koren G (1994) Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. J Clin Pharmacol 34:944–949

    Article  CAS  PubMed  Google Scholar 

  57. Mathes T, Antoine SL, Pieper D, Eikermann M (2014) Adherence enhancing interventions for oral anticancer agents: a systematic review. Cancer Treat Rev 40:102–108

    Article  PubMed  Google Scholar 

  58. Kahana S, Drotar D, Frazier T (2008) Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. J Pediatr Psychol 3:590–611

    Article  Google Scholar 

  59. Graves MM, Roberts MC, Rapoff M, Boyer A (2010) The efficacy of adherence interventions for chronically ill children: a meta-analytic review. J Pediatr Psychol 35:368–382

    Article  PubMed  Google Scholar 

  60. Murphy MH (2013) Health promotion in adolescent and young adult cancer survivors: mobilizing compliance in a multifaceted risk profile. J Pediatr Oncol Nurs 30:139–152

    Article  PubMed  Google Scholar 

  61. Modi AC, Crosby LE, Hines J, Drotar D, Mitchell MJ (2012) Feasibility of web-based technology to assess adherence to clinic appointments in youth with sickle cell disease. J Pediatr Hematol Oncol 34:e93–e96

    Article  PubMed  PubMed Central  Google Scholar 

  62. Crosby LE, Barach I, McGrady ME, Kalinyak KA, Eastin AR, Mitchell MJ (2012) Integrating interactive web-based technology to assess adherence and clinical outcomes in pediatric sickle cell disease. Anemia 2012:492428

    Article  PubMed  PubMed Central  Google Scholar 

  63. Zebrack B, Mathews-Bradshaw B, Siegel S, LIVESTRONG Young Adult Alliance (2010) Quality cancer care for adolescents and young adults: a position statement. J Clin Oncol 28:4862–4867

    Article  PubMed  Google Scholar 

  64. van Staa AL, Jedeloo S, van Meeteren J, Latour JM (2011) Crossing the transition chasm: experiences and recommendations for improving transitional care of young adults, parents and providers. Child Care Health Dev 37:821–832

    Article  PubMed  Google Scholar 

  65. Burgess SW, Sly PD, Devadason SG (2010) Providing feedback on adherence increases use of preventive medication by asthmatic children. J Asthma 47:198–201

    Article  PubMed  Google Scholar 

  66. De Bruin M, Hospers HJ, van Breukelen GJ, Kok G, Koevoets WM, Prins JM (2010) Electronic monitoring-based counseling to enhance adherence among HIV-infected patients: a randomized controlled trial. Health Psychol 29:421–428

    Article  PubMed  Google Scholar 

  67. Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, De Geest S, Dobbels F, Lewek P, Urquhart J, Vrijens B, ABC Project Team (2013) Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs 73:545–562

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Fitzpatrick SL, Schumann KP, Hill-Briggs F (2013) Problem solving interventions for diabetes self-management and control: a systematic review of the literature. Diabetes Res Clin Pract 100:145–161

    Article  PubMed  PubMed Central  Google Scholar 

  69. Kyngas HA, Kroll T, Duffy ME (2000) Compliance in adolescents with chronic diseases: a review. J Adolesc Health 26:379–388

    Article  CAS  PubMed  Google Scholar 

  70. Gayes LA, Steele RG (2014) A meta-analysis of motivational interviewing interventions for pediatric health behavior change. J Consult Clin Psychol 82:521–535

    Article  PubMed  Google Scholar 

  71. Salema NE, Elliott RA, Glazebrook C (2011) A systematic review of adherence-enhancing interventions in adolescents taking long-term medicines. J Adolesc Health 49:455–466

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Adolescent Medicine, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada

    Ashley Vandermorris MD

  2. Division of Pediatric Hematology-Oncology, University of Alabama at Birmingham, Birmingham, AL, USA

    Kerry W. Parsons PharmD

  3. Pediatric Oncology Group of Ontario, Toronto, ON, Canada

    Mark L. Greenberg MB ChB

Authors
  1. Ashley Vandermorris MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kerry W. Parsons PharmD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark L. Greenberg MB ChB
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashley Vandermorris MD .

Editor information

Editors and Affiliations

  1. Bend, Oregon, USA

    Archie Bleyer

  2. McMaster University, Hamilton, Ontario, Canada

    Ronald Barr

  3. RiesSearch LLC, Rockville, Maryland, USA

    Lynn Ries

  4. University College Hospital, London, United Kingdom

    Jeremy Whelan

  5. Pediatric Oncology Unit, National Tumor Institute, Milano, Italy

    Andrea Ferrari

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing

About this chapter

Cite this chapter

Vandermorris, A., Parsons, K.W., Greenberg, M.L. (2017). Adherence to Treatment Regimes in Adolescent and Young Adult Cancer Patients. In: Bleyer, A., Barr, R., Ries, L., Whelan, J., Ferrari, A. (eds) Cancer in Adolescents and Young Adults. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-33679-4_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33679-4_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33677-0

  • Online ISBN: 978-3-319-33679-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation